trending Market Intelligence /marketintelligence/en/news-insights/trending/TdE5CvKKHo9ksskhty2QYQ2 content esgSubNav
In This List

Summit Therapeutics CFO to resign

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


Summit Therapeutics CFO to resign

Summit Therapeutics PLC said Erik Ostrowski would step down as CFO at the end of December.

"The company will appoint a new chief financial officer in due course," Summit Therapeutics said.

Abingdon, U.K.-based Summit Therapeutics is a biopharmaceutical company that focuses on the discovery, development and commercialization of novel medicines to treat rare and infectious diseases.